Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Neven, Bénédicte  [Clear All Filters]
2023
Petit A, Neven B, Min V, Mahlaoui N, Moshous D, Castelle M, Allouche M, Stérin A, Visentin S, Saultier P, et al. Impact of graft function on health status and quality of life in 112 very long-term survivors who received an HSCT for Inborn Errors of Immunity, a prospective study of the CEREDIH. Transplant Cell Ther. 2023.
Nishimura A, Uppuluri R, Raj R, Swaminathan VVellaicham, Cheng Y, Abu-Arja RF, Fu B, Laberko A, Albert MH, Hauck F, et al. An International Survey of Allogeneic Hematopoietic Cell Transplantation for X-Linked Agammaglobulinemia. J Clin Immunol. 2023.
Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, von Bismarck P, Bloomfield MPhDMarké, Booth C, Buddingh EP, et al. JAK-inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID and EBMT IEWP retrospective study. J Allergy Clin Immunol. 2023.
César T, Le MP, Klifa R, Castelle M, Fournier B, Levy R, Chbihi M, Courteille V, Moshous D, Blanche S, et al. Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity. J Clin Immunol. 2023;44(1):6.
Yakoub-Agha I, Greco R, Onida F, de la Camara R, Ciceri F, Corbacioglu S, Dolstra H, Glass B, Kenyon M, McLornan DP, et al. Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy. Bone Marrow Transplant. 2023.
von Asmuth EGj, Neven B, Albert MH, Mohseny AB, Schilham MW, Binder H, Putter H, Lankester AC. Predicting patient death after allogeneic SCT for inborn errors using machine learning (PREPAD): An EBMT IEWP study. Transplant Cell Ther. 2023.

Pages